Regen Therapeutics Recognized as Georgia's Preferred Regenerative Hair Restoration Practice

Regen Therapeutics has been selected by Georgia medical professionals as the preferred regenerative hair restoration practice in the state, recognizing its commitment to safety, innovation, and medically supervised post-chemotherapy hair recovery. The Sandy Springs-based practice specializes in regenerative hair restoration using advanced biologic therapies and all-natural, non-prescription support protocols, working exclusively with patients who have completed chemotherapy and received medical clearance from their oncology teams. This recognition underscores the clinic's patient-first philosophy and rigorous adherence to regulatory standards throughout the treatment process.

The practice utilizes umbilical cord–derived regenerative biologics obtained from full-term, healthy cesarean-section deliveries with proper consent and verification. All biologic material is processed in FDA-regulated, cGMP-compliant laboratories and screened under FDA infectious-disease standards before being administered via localized scalp injections to support follicle regeneration. Clinic Director Dr. Keith D. Kantor emphasized that no patient begins treatment without explicit oncology clearance, stating that collaboration with medical professionals is essential for patient safety. The clinic's protocols are strictly non-drug-based and include nutrient-based topical therapies, natural topical DHT blockers, and scalp stimulation treatments, all introduced only after oncology approval and chemotherapy completion.

Regen Therapeutics' program is specifically designed for patients experiencing post-chemotherapy hair thinning and scalp health challenges, with the clinic providing structured communication and documentation to oncology partners to ensure coordinated care. The practice maintains strict patient acceptance criteria and will only see post-chemotherapy patients with documented approval from their treating oncologist. To further support oncology patients, Regen Therapeutics offers a 25% referral discount, priority appointment scheduling, and post-treatment support guidance. Dr. Kantor explained that their role begins only after cancer treatment has concluded, working with oncologists to support patients during the emotional recovery phase as they regain a sense of normalcy.

The recognition by Georgia's medical community highlights Regen Therapeutics' leadership in regenerative hair restoration and its approach that avoids prescription hair-loss drugs in favor of regenerative biologics and natural therapies within regulatory guidelines. The practice's commitment to safety and medical collaboration has established it as a trusted partner in post-cancer care, addressing both the physical and emotional aspects of hair restoration for chemotherapy patients. This designation as the preferred practice reflects growing acceptance of regenerative approaches in medical communities and sets standards for patient safety protocols in specialized hair restoration services.